Kovitz Investment Group Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-67,192
Closed -$6.62M 1371
2025
Q3
$6.62M Buy
67,192
+2,803
+4% +$278K 0.03% 408
2025
Q2
$5.87M Buy
64,389
+1,320
+2% +$128K 0.03% 418
2025
Q1
$7.14M Sell
63,069
-348
-0.5% -$37.2K 0.04% 336
2024
Q4
$6.7M Sell
63,417
-116
-0.2% -$12.4K 0.03% 343
2024
Q3
$6.66M Buy
63,533
+1,109
+2% +$121K 0.05% 297
2024
Q2
$6.77M Sell
62,424
-1,392
-2% -$164K 0.06% 236
2024
Q1
$8.42M Buy
63,816
+8,901
+16% +$1.11M 0.11% 142
2023
Q4
$6.68M Sell
54,915
-604
-1% -$67.4K 0.11% 110
2023
Q3
$6.23M Sell
55,519
-974
-2% -$124K 0.11% 108
2023
Q2
$8.23M Sell
56,493
-425
-0.7% -$57.8K 0.12% 85
2023
Q1
$7.35M Buy
56,918
+958
+2% +$120K 0.13% 100
2022
Q4
$7.13M Sell
55,960
-223
-0.4% -$25.9K 0.14% 103
2022
Q3
$5.87M Sell
56,183
-127
-0.2% -$13.9K 0.14% 107
2022
Q2
$5.92M Sell
56,310
-201
-0.4% -$23.8K 0.13% 119
2022
Q1
$7.23M Buy
56,511
+14,362
+34% +$1.73M 0.14% 110
2021
Q4
$6.31M Sell
42,149
-640
-1% -$83.8K 0.15% 101
2021
Q3
$6.08M Sell
42,789
-159
-0.4% -$23.4K 0.12% 126
2021
Q2
$6.71M Sell
42,948
-164
-0.4% -$26.6K 0.13% 119
2021
Q1
$6.7M Buy
43,112
+963
+2% +$149K 0.16% 100
2020
Q4
$6.31M Sell
42,149
-1,125
-3% -$159K 0.15% 98
2020
Q3
$5.72M Sell
43,274
-316
-0.7% -$41.3K 0.16% 103
2020
Q2
$5.05M Sell
43,590
-2,137
-5% -$246K 0.16% 103
2020
Q1
$4.49M Sell
45,727
-2,314
-5% -$303K 0.16% 101
2019
Q4
$6.98M Sell
48,041
-920
-2% -$127K 0.2% 79
2019
Q3
$6.53M Sell
48,961
-808
-2% -$104K 0.21% 84
2019
Q2
$5.69M Buy
49,769
+17
+0% +$1.99K 0.18% 89
2019
Q1
$6.17M Sell
49,752
-76
-0.2% -$8.64K 0.2% 79
2018
Q4
$5.02M Buy
+49,828
New +$5.6M 0.2% 84

Other funds holding ZBH

Kovitz Investment Group Partners's ZBH Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 67,192 shares — an estimated $6.62M sold.

Kovitz Investment Group Partners first reported a position in ZBH in Q4 2018 and held it in 28 quarters. The position peaked at $8.42M in Q1 2024. 947 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 67,192 Zimmer Biomet shares in Q4 2025, an estimated $6.62M.
  • Kovitz Investment Group Partners first reported a position in Zimmer Biomet in Q4 2018 and held it in 28 quarters.
  • Kovitz Investment Group Partners's Zimmer Biomet position peaked at $8.42M in Q1 2024.
  • 947 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.